pubmed-article:12196481 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12196481 | lifeskim:mentions | umls-concept:C0017687 | lld:lifeskim |
pubmed-article:12196481 | lifeskim:mentions | umls-concept:C0017337 | lld:lifeskim |
pubmed-article:12196481 | lifeskim:mentions | umls-concept:C0020456 | lld:lifeskim |
pubmed-article:12196481 | lifeskim:mentions | umls-concept:C0032821 | lld:lifeskim |
pubmed-article:12196481 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
pubmed-article:12196481 | lifeskim:mentions | umls-concept:C0221099 | lld:lifeskim |
pubmed-article:12196481 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
pubmed-article:12196481 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
pubmed-article:12196481 | lifeskim:mentions | umls-concept:C1416578 | lld:lifeskim |
pubmed-article:12196481 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
pubmed-article:12196481 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
pubmed-article:12196481 | lifeskim:mentions | umls-concept:C1882417 | lld:lifeskim |
pubmed-article:12196481 | lifeskim:mentions | umls-concept:C1709866 | lld:lifeskim |
pubmed-article:12196481 | lifeskim:mentions | umls-concept:C0301625 | lld:lifeskim |
pubmed-article:12196481 | pubmed:issue | 9 | lld:pubmed |
pubmed-article:12196481 | pubmed:dateCreated | 2002-8-28 | lld:pubmed |
pubmed-article:12196481 | pubmed:abstractText | Genetic factors play an important role in the pathogenesis of type 2 diabetes. The relevance to type 2 diabetes of the common polymorphism Glu23Lys in the potassium inward rectifier 6.2 (KIR6.2) gene is still controversial. The aim of this study was to assess whether this polymorphism influences beta-cell function, alpha-cell function, or insulin action. We therefore studied 298 nondiabetic subjects using an oral glucose tolerance test (OGTT) and 75 nondiabetic subjects using a hyperglycemic clamp (10 mmol/l) with additional glucagon-like peptide (GLP)-1 and arginine stimulation. The prevalence of the Lys allele was approximately 37%, and the Lys allele was associated with higher incremental plasma glucose during the OGTT (P = 0.03, ANOVA). Neither first- nor second-phase glucose-stimulated C-peptide secretion was affected by the presence of the polymorphism; nor were maximal glucose-, GLP-1-, or arginine-induced C-peptide secretion rates; nor was insulin sensitivity (all P > 0.7). However, the relative decrease in plasma glucagon concentrations during the 10 min after the glucose challenge was reduced in carriers of the Lys allele (10 +/- 3% decrease from baseline in Lys/Lys, 18 +/- 2% in Glu/Lys, and 20 +/- 2% in Glu/Glu; P = 0.01, ANOVA). In conclusion, our findings suggest that the common Glu23Lys polymorphism in KIR6.2 is not necessarily associated with beta-cell dysfunction or insulin resistance but with diminished suppression of glucagon secretion in response to hyperglycemia. Our findings thus confirm its functional relevance for glucose metabolism in humans. | lld:pubmed |
pubmed-article:12196481 | pubmed:language | eng | lld:pubmed |
pubmed-article:12196481 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12196481 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:12196481 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12196481 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12196481 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12196481 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12196481 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12196481 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12196481 | pubmed:month | Sep | lld:pubmed |
pubmed-article:12196481 | pubmed:issn | 0012-1797 | lld:pubmed |
pubmed-article:12196481 | pubmed:author | pubmed-author:MachicaoFaust... | lld:pubmed |
pubmed-article:12196481 | pubmed:author | pubmed-author:StumvollMicha... | lld:pubmed |
pubmed-article:12196481 | pubmed:author | pubmed-author:TschritterOtt... | lld:pubmed |
pubmed-article:12196481 | pubmed:author | pubmed-author:FritscheAndre... | lld:pubmed |
pubmed-article:12196481 | pubmed:author | pubmed-author:WeisserMelani... | lld:pubmed |
pubmed-article:12196481 | pubmed:author | pubmed-author:HäringHansH | lld:pubmed |
pubmed-article:12196481 | pubmed:author | pubmed-author:MaerkerElkeE | lld:pubmed |
pubmed-article:12196481 | pubmed:author | pubmed-author:TeigelerAnnaA | lld:pubmed |
pubmed-article:12196481 | pubmed:author | pubmed-author:HolzwarthMart... | lld:pubmed |
pubmed-article:12196481 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12196481 | pubmed:volume | 51 | lld:pubmed |
pubmed-article:12196481 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12196481 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12196481 | pubmed:pagination | 2854-60 | lld:pubmed |
pubmed-article:12196481 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:12196481 | pubmed:meshHeading | pubmed-meshheading:12196481... | lld:pubmed |
pubmed-article:12196481 | pubmed:meshHeading | pubmed-meshheading:12196481... | lld:pubmed |
pubmed-article:12196481 | pubmed:meshHeading | pubmed-meshheading:12196481... | lld:pubmed |
pubmed-article:12196481 | pubmed:meshHeading | pubmed-meshheading:12196481... | lld:pubmed |
pubmed-article:12196481 | pubmed:meshHeading | pubmed-meshheading:12196481... | lld:pubmed |
pubmed-article:12196481 | pubmed:meshHeading | pubmed-meshheading:12196481... | lld:pubmed |
pubmed-article:12196481 | pubmed:meshHeading | pubmed-meshheading:12196481... | lld:pubmed |
pubmed-article:12196481 | pubmed:meshHeading | pubmed-meshheading:12196481... | lld:pubmed |
pubmed-article:12196481 | pubmed:meshHeading | pubmed-meshheading:12196481... | lld:pubmed |
pubmed-article:12196481 | pubmed:meshHeading | pubmed-meshheading:12196481... | lld:pubmed |
pubmed-article:12196481 | pubmed:meshHeading | pubmed-meshheading:12196481... | lld:pubmed |
pubmed-article:12196481 | pubmed:meshHeading | pubmed-meshheading:12196481... | lld:pubmed |
pubmed-article:12196481 | pubmed:meshHeading | pubmed-meshheading:12196481... | lld:pubmed |
pubmed-article:12196481 | pubmed:meshHeading | pubmed-meshheading:12196481... | lld:pubmed |
pubmed-article:12196481 | pubmed:year | 2002 | lld:pubmed |
pubmed-article:12196481 | pubmed:articleTitle | The prevalent Glu23Lys polymorphism in the potassium inward rectifier 6.2 (KIR6.2) gene is associated with impaired glucagon suppression in response to hyperglycemia. | lld:pubmed |
pubmed-article:12196481 | pubmed:affiliation | Department of Endocrinology, Metabolism and Pathobiochemistry, Medizinische Klinik, Eberhard-Karls-Universität, Tübingen, Germany. | lld:pubmed |
pubmed-article:12196481 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12196481 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:3767 | entrezgene:pubmed | pubmed-article:12196481 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:12196481 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:12196481 | lld:entrezgene |
lhgdn:association:58264 | lhgdn:found_in | pubmed-article:12196481 | lld:lhgdn |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12196481 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12196481 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12196481 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12196481 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12196481 | lld:pubmed |